CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Whether CYP2E1 in both ER and mitochondria work simultaneously or sequentially, and whether mitochondrial CYP2E1 exerts more pronounced effects on mitochondrial dysfunction in AFLD and NAFLD, is unclear due to lack of specific inhibitors [82].